AU2002217228A1 - Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses - Google Patents

Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses

Info

Publication number
AU2002217228A1
AU2002217228A1 AU2002217228A AU1722802A AU2002217228A1 AU 2002217228 A1 AU2002217228 A1 AU 2002217228A1 AU 2002217228 A AU2002217228 A AU 2002217228A AU 1722802 A AU1722802 A AU 1722802A AU 2002217228 A1 AU2002217228 A1 AU 2002217228A1
Authority
AU
Australia
Prior art keywords
isocoumarin
preparation
compositions containing
amyloid peptide
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217228A
Inventor
Frederic Bihel
Michel Delaage
Cyrille Drouot
Caroline Jouve
Jean-Louis Kraus
Olivier Pourquie
Toni-Louise Williamson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trophos SA
Original Assignee
Trophos SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophos SA filed Critical Trophos SA
Publication of AU2002217228A1 publication Critical patent/AU2002217228A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002217228A 2000-12-11 2001-12-10 Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses Abandoned AU2002217228A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR00/16060 2000-12-11
FR0016060A FR2817867B1 (en) 2000-12-11 2000-12-11 ISOCOUMARINS INHIBITORS OF AMYLOID PEPTIDE PRODUCTION, PREPARATION, COMPOSITIONS CONTAINING SAME AND USES THEREOF
PCT/FR2001/003902 WO2002048102A2 (en) 2000-12-11 2001-12-10 Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses

Publications (1)

Publication Number Publication Date
AU2002217228A1 true AU2002217228A1 (en) 2002-06-24

Family

ID=8857475

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217228A Abandoned AU2002217228A1 (en) 2000-12-11 2001-12-10 Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses

Country Status (3)

Country Link
AU (1) AU2002217228A1 (en)
FR (1) FR2817867B1 (en)
WO (1) WO2002048102A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845242A (en) * 1987-04-28 1989-07-04 Georgia Tech Research Corporation Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
US4596822A (en) * 1984-08-20 1986-06-24 Georgia Tech Research Corporation Heterocyclic inhibitors of serine proteases
US5089633A (en) * 1987-04-28 1992-02-18 Georgia Tech Research Corporation Substituted isocoumarins
EP0564552A1 (en) * 1990-12-28 1993-10-13 Cortex Pharmaceuticals, Inc. Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
IL110525A0 (en) * 1993-08-09 1994-11-11 Lilly Co Eli Identification and use of protease inhibitors

Also Published As

Publication number Publication date
WO2002048102A2 (en) 2002-06-20
FR2817867B1 (en) 2006-06-30
FR2817867A1 (en) 2002-06-14
WO2002048102A3 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2002233929A1 (en) Compositions of peptide crystals
AU2001262475A1 (en) Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
AU2001293564A1 (en) Point of sale terminal
PL363153A1 (en) Chemically-modified antimicrobial peptides, compositions and methods of production and use
MY127316A (en) Encapsulation of food ingredients
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
DZ3311A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2002246734A1 (en) Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers
AU3560601A (en) Novel isoquinoline derivatives, preparation method and pharmaceutical compositions containing them
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU5469501A (en) Proliposomal encapsulated preparation
AU2001265935A1 (en) Production of biohydrolysates
AU2002222148A1 (en) Preparation of spheroids
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU2002217228A1 (en) Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2002212327A1 (en) Pharmaceutical preparation comprised of milk-thistle and terpenes
AU4876701A (en) Peptide derivatives and medicinal compositions
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
HUP0303688A3 (en) Propanolaminotetralines, preparation thereof and pharmaceutical compositions containing same
AU2001220267A1 (en) Novel 1beta-methylcarbapenem derivatives and process of preparation thereof
ZA200001843B (en) Preparation of standard gas mixtures.
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002216038A1 (en) Preparation of monofluoroalkenes